List of Excipients in API dexmedetomidine hydrochloride
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing dexmedetomidine hydrochloride
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Henry Schein Inc | PRECEDEX | dexmedetomidine hydrochloride | 0404-9938 | SODIUM CHLORIDE | |
| Henry Schein Inc | PRECEDEX | dexmedetomidine hydrochloride | 0404-9938 | WATER | |
| Hospira Inc | PRECEDEX | dexmedetomidine hydrochloride | 0409-1454 | SODIUM CHLORIDE | |
| Hospira Inc | PRECEDEX | dexmedetomidine hydrochloride | 0409-1454 | WATER | |
| Hospira Inc | PRECEDEX | dexmedetomidine hydrochloride | 0409-1660 | SODIUM CHLORIDE | |
| Hospira Inc | PRECEDEX | dexmedetomidine hydrochloride | 0409-1660 | WATER | |
| Hospira Inc | PRECEDEX | dexmedetomidine hydrochloride | 0409-4596 | SODIUM CHLORIDE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing dexmedetomidine hydrochloride
Detailed excipient profiles for dexmedetomidine hydrochloride
Excipient focus: ACETIC ACID
dexmedetomidine hydrochloride drug variants containing ACETIC ACID
dexmedetomidine hydrochloride drug variants not containing ACETIC ACID
Excipient focus: METHIONINE
dexmedetomidine hydrochloride drug variants containing METHIONINE
| Company | Ingredient | NDC |
|---|---|---|
| Slayback Pharma LLC | dexmedetomidine hydrochloride | 71225-126 |
| Slayback Pharma LLC | dexmedetomidine hydrochloride | 71225-132 |
| CIVICA INC | dexmedetomidine hydrochloride | 72572-127 |
| >Company | >Ingredient | >NDC |
dexmedetomidine hydrochloride drug variants not containing METHIONINE
Excipient focus: METHYLPARABEN
dexmedetomidine hydrochloride drug variants containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Somerset Therapeutics LLC | dexmedetomidine hydrochloride | 70069-758 |
| >Company | >Ingredient | >NDC |
dexmedetomidine hydrochloride drug variants not containing METHYLPARABEN
Excipient focus: NITROGEN
dexmedetomidine hydrochloride drug variants containing NITROGEN
| Company | Ingredient | NDC |
|---|---|---|
| Somerset Therapeutics LLC | dexmedetomidine hydrochloride | 70069-758 |
| >Company | >Ingredient | >NDC |
dexmedetomidine hydrochloride drug variants not containing NITROGEN
Excipient focus: PROPYLPARABEN
dexmedetomidine hydrochloride drug variants containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Somerset Therapeutics LLC | dexmedetomidine hydrochloride | 70069-758 |
| >Company | >Ingredient | >NDC |
dexmedetomidine hydrochloride drug variants not containing PROPYLPARABEN
Excipient focus: SODIUM ACETATE
dexmedetomidine hydrochloride drug variants containing SODIUM ACETATE
dexmedetomidine hydrochloride drug variants not containing SODIUM ACETATE
Excipient focus: SODIUM CHLORIDE
dexmedetomidine hydrochloride drug variants containing SODIUM CHLORIDE
dexmedetomidine hydrochloride drug variants not containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
dexmedetomidine hydrochloride drug variants containing WATER
dexmedetomidine hydrochloride drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | dexmedetomidine hydrochloride | 0143-9526 |
| Fresenius Kabi USA LLC | dexmedetomidine hydrochloride | 63323-421 |
| Fresenius Kabi USA LLC | dexmedetomidine hydrochloride | 63323-671 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
